Description
Moluzen Molnupiravir 200 mg Capsules
Effective oral antiviral for early treatment of mild to moderate COVID-19 in adults
Product Description
Moluzen contains Molnupiravir 200 mg, an oral antiviral medication used to treat mild to moderate COVID-19 in adults at risk of progressing to severe illness. It works by stopping the SARS-CoV-2 virus from replicating in the body, helping to reduce viral load and disease severity.
Recommended to start treatment within 5 days of symptom onset for best results. This medication requires a prescription and medical supervision.
Benefits
- Reduces risk of hospitalization and severe COVID-19 complications
- Oral capsule, easy to take without injections
- Short 5-day treatment course
- Works against multiple COVID-19 variants
Dosage & Administration
- Dosage: 800 mg (4 capsules) twice daily
- Duration: 5 days
- Start within 5 days of symptom onset
- Take with or without food
- Do not skip doses; complete the full course
Precautions & Warnings
- Not recommended for pregnant or breastfeeding women
- Use contraception during and after treatment (men: 3 months, women: 4 days)
- Not approved for children under 18 years
- Consult your doctor if you have kidney or liver issues
Frequently Asked Questions (FAQs)
What is Moluzen Molnupiravir 200 mg?
It is an oral antiviral medication used for treating mild to moderate COVID-19 in adults at risk of severe disease.
When should I start taking Moluzen?
Start treatment within 5 days of first COVID-19 symptoms for effective results.
Can pregnant or breastfeeding women take Moluzen?
No, Moluzen is not recommended during pregnancy or breastfeeding.
Are there any side effects?
Possible side effects include headache, nausea, and diarrhea, which are usually mild and temporary.
Is a prescription required?
Yes, Moluzen requires a prescription and should be used under medical supervision.